Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Doctor Vs Comedian

Episode 84: Interview with Bilal Baig (‘Sort Of’)

07 Oct 2022

Description

Today on a special episode, Ali and Asif interview Bilal Baig, star of the CBC and HBO Max series “Sort of” who made history by Made history by being the first South Asian, queer Muslim actor to star in a Canadian prime-time TV series. The guys start off by asking Bilal about their early life and growing up as a second generation South Asian in the Toronto area. Bilal talks about how initially they were a shy child but eventually found writing and theatre as a calling. Bilal then talks about the creation of their play “Acha Bacha”.  They then describe creating ‘Sort Of’ with Fab Filippo. Ali asks Bilal about their comedy influences and their dry sense of humor displayed in ‘Sort Of’. All three then discuss the success and critical accolades given to ‘Sort Of’ (whose second season premieres Nov 15 on CBC and Dec 1 on HBO Max). The opinions expressed are those of the hosts, and do not reflect those of any other organizations. This podcast and website represents the opinions of the hosts. The content here should not be taken as medical advice. The content here is for entertainment and informational purposes only, and because each person is so unique, please consult your healthcare professional for any medical questions.  Music courtesy of Wataboi and 8er41 from Pixabay Contact us at [email protected] Follow us on Social media:Twitter: @doctorvcomedianInstagram: doctorvcomedian Show Notes:‘Sort Of’: https://gem.cbc.ca/media/sort-of/s01Rotten Tomatoes ‘Sort Of’: https://www.rottentomatoes.com/tv/sort_of/s01 Hosted on Acast. See acast.com/privacy for more information.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.